CB
ALNY icon

Commerce Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History

Commerce Bank’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.85M Sell
9,461
-19
-0.2% -$5.73K 0.01% 484
2026
Q1 		$3.14M Sell
9,480
-1,053
-10% -$358K 0.02% 438
2025
Q4 		$4.19M Buy
10,533
+6,002
+132% +$2.66M 0.02% 343
2025
Q3 		$2.07M Sell
4,531
-5
-0.1% -$2.04K 0.01% 495
2025
Q2 		$1.48M Sell
4,536
-21
-0.5% -$5.81K 0.01% 550
2025
Q1 		$1.23M Buy
4,557
+55
+1% +$14.1K 0.01% 576
2024
Q4 		$1.06M Sell
4,502
-20
-0.4% -$5.26K 0.01% 618
2024
Q3 		$1.24M Sell
4,522
-95
-2% -$24.7K 0.01% 588
2024
Q2 		$1.12M Sell
4,617
-39
-0.8% -$6.16K 0.01% 597
2024
Q1 		$696K Sell
4,656
-27
-0.6% -$4.5K ﹤0.01% 739
2023
Q4 		$896K Buy
4,683
+77
+2% +$13.1K 0.01% 641
2023
Q3 		$816K Buy
4,606
+28
+0.6% +$5.34K 0.01% 628
2023
Q2 		$870K Sell
4,578
-30
-0.7% -$5.95K 0.01% 612
2023
Q1 		$923K Buy
4,608
+158
+4% +$33.2K 0.01% 582
2022
Q4 		$1.06M Sell
4,450
-27
-0.6% -$5.76K 0.01% 547
2022
Q3 		$896K Sell
4,477
-20,170
-82% -$3.85M 0.01% 572
2022
Q2 		$3.6M Buy
24,647
+20,289
+466% +$2.88M 0.03% 335
2022
Q1 		$712K Buy
4,358
+100
+2% +$15.2K ﹤0.01% 689
2021
Q4 		$722K Buy
4,258
+21
+0.5% +$3.9K ﹤0.01% 722
2021
Q3 		$800K Sell
4,237
-1,604
-27% -$301K 0.01% 678
2021
Q2 		$990K Buy
5,841
+53
+0.9% +$7.76K 0.01% 614
2021
Q1 		$817K Sell
5,788
-33,798
-85% -$5.09M 0.01% 653
2020
Q4 		$5.14M Buy
39,586
+5,051
+15% +$674K 0.04% 298
2020
Q3 		$5.03M Buy
34,535
+3,267
+10% +$464K 0.05% 264
2020
Q2 		$4.63M Buy
31,268
+26,788
+598% +$3.61M 0.05% 265
2020
Q1 		$488K Buy
4,480
+1,390
+45% +$160K 0.01% 594
2019
Q4 		$356K Buy
+3,090
New +$308K ﹤0.01% 768

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Commerce Bank's ALNY Position: Q2 2026 in Review

Commerce Bank reduced its Alnylam Pharmaceuticals (ALNY) stake by 0.2% in Q2 2026, selling an estimated $5.73K and leaving 9,461 shares worth $2.85M. The position accounts for 0.01% of the portfolio, ranked #484.

Commerce Bank first reported a position in ALNY in Q4 2019 and has held it in 27 quarters since. The position peaked at $5.14M in Q4 2020. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Commerce Bank held 9,461 shares of Alnylam Pharmaceuticals worth $2.85M as of Q2 2026.
  • Commerce Bank sold 19 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $5.73K.
  • Alnylam Pharmaceuticals made up 0.01% of Commerce Bank's portfolio in Q2 2026, its #484 holding.
  • Commerce Bank first reported a position in Alnylam Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • Commerce Bank's Alnylam Pharmaceuticals position peaked at $5.14M in Q4 2020.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Commerce Bank's 13F filing for Q2 2026, filed 12 Aug 2026.